% OF PATIENTS TESTED
PATIENTS w/ TARGETABLE ALTERATIONS
Only the right testing drives the right treatment decisions
Test every newly diagnosed NSCLC patient for all 10 NCCN guideline biomarkers. Every time.
Wait for complete results to determine the most effective therapy.
Confidently choose the best possible first-line treatment - targeted therapy or immunotherapy +/- chemotherapy.
A thriving community of patient organizations advocate for complete testing before treatment.